Abstract
Alpha1 adrenoceptor antagonists are safe, effective, well tolerated drugs which can be used alone or in combination with other drug groups in a wide range of hypertensive patients. Alpha1 blockers not only lower blood pressure but may improve insulin sensitivity and the adverse lipid profile in many hypertensive patients. In addition to causing few side effects, alpha1 blockers are not contra-indicated in patients with associated cardiovascular or respiratory disease. Alpha1 blockers offer the potential to improve the risk factor profile more than conventional antihypertensive drugs.